Gilda Malek Sells MGRC Shares

Gilda Malek, the Senior Vice President and Chief Legal Officer at MGRC, sold 1,407 shares of the company on June 15, 2026. The shares were sold at an average price of $114.04, bringing the total transaction value to approximately $160,454. This sale was not part of a pre-arranged trading plan.

Insider Buying and Selling at MGRC

In addition to Gilda Malek's recent sale, other insiders have also been selling shares. Kristina Van Trease, the Chief Strategy Officer, sold 3,783 shares at $113.65 each on June 10, 2026. David Whitney, the SVP and Chief Accounting Officer, also sold 3,783 shares on the same date at the same price. Earlier in May, both Whitney and Van Trease sold additional shares at $115.00 per share.

Other Institutional Activity in MGRC

Institutional investors have also been active in MGRC. River Road Asset Management, LLC increased its stake by 29,716 shares, ending with 2,160,837 shares valued at about $238.3 million. BlackRock, Inc. trimmed its position by 22,911 shares, leaving it with 1,940,522 shares worth approximately $214 million. Vanguard Portfolio Management LLC and Vanguard Capital Management LLC both established new positions with 1,407,014 and 1,110,094 shares, respectively. Dimensional Fund Advisors LP added 47,451 shares, bringing its total to 906,954 shares valued at about $100 million.

Analysts Set New Price Targets

Barclays initiated coverage of MGRC with a buy rating and a price target of $140 on February 12, 2026. Oppenheimer has maintained a buy rating on the stock, setting a price target of $143 back in September 2025. CJS Securities assumed coverage with a buy rating and a $152 target in December 2024. The consensus among analysts is a buy rating, with an average target price of $140.

Bottom Line

Gilda Malek's recent sale of MGRC shares adds to a series of insider transactions at the company. While insider selling can happen for many reasons, it often draws attention from investors. Institutional activity shows a mix of buying and selling, indicating varied sentiment. Analyst coverage remains positive, with several firms maintaining buy ratings and setting high price targets. Remember, insider transactions and 13F filings are backward-looking and may not reflect current positions.